Trials / Unknown
UnknownNCT03324867
The Effect of Intranasal Insulin Administration on Cognitive Function After Cardiac Surgery.
The Effect of Intranasal Insulin Administration on Cognitive Function After Cardiac Surgery
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 316 (estimated)
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
Decline in cognitive function after surgery occurs most commonly in older patients and patients undergoing major surgeries, such as heart surgery. Postoperative Cognitive Dysfunction (POCD) may last a prolonged period of time while Postoperative Delirium (POD) is a more acute disturbance in attention, awareness and cognition. The cause of POCD and POD are not fully understood, however some of the pathophysiology of POCD is similar to that of Alzheimer's disease (AD). Insulin given intravenously during heart surgery has been shown to preserve short and long-term memory function after the operation. Clinical trials further demonstrated that insulin given via the nose (intranasal) improves memory performance of patients with AD or cognitive impairment suggests that intranasal insulin also could be a therapeutic option for POCD and POD. This study is designed to examine the effect intranasal insulin on POCD and POD. The goal is to investigate whether administration of intranasal insulin during and after heart surgery improves cognitive function postoperatively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Regular insulin | 40 IU of Humulin-R to be administered via nose using metered nasal dispenser prior to surgery, and up to 7 days after surgery. |
| DRUG | Normal Saline Flush, 0.9% Injectable Solution | Placebo: Normal Saline to be administered via nose using metered nasal dispenser prior to surgery, and up to 7 days after surgery |
Timeline
- Start date
- 2022-04-01
- Primary completion
- 2023-04-01
- Completion
- 2023-04-01
- First posted
- 2017-10-30
- Last updated
- 2021-01-26
Source: ClinicalTrials.gov record NCT03324867. Inclusion in this directory is not an endorsement.